---
created_at: '2026-06-20T08:17:20Z'
source_papers:
- '[[openalex-2606.18640-metabonet-bench-a-multi-modal-benchmark-for-glucose-forecast]]'
title: Clinical Evaluation Metric Standardization
---

**Background:** Glucose forecasting models in type 1 diabetes often rely on traditional aggregate performance metrics like RMSE or MARD, which can fail to capture clinically important error characteristics in extreme glycemic ranges.

**Question / Future Work:** There is a need to develop and prioritize evaluation metrics that better reflect clinical safety and utility, specifically by addressing performance imbalances in hypoglycemic and hyperglycemic ranges, where forecasting errors carry significant risks. Future work should emphasize clinical relevance, such as how accurately models predict glucose excursions during critical physiological perturbations like hypoglycemia.

**Why It Matters:** Standardizing clinically sensitive metrics is crucial for ensuring that models designed for AID systems are safe for extreme glucose states, rather than just accurate on average.

**Evidence:** However, existing benchmarks typically employ a limited subset of these metrics. For example, prior benchmarks often emphasize aggregate performance metrics, leaving model performance with respect to clinically important error characteristics in hypoglycemic versus hyperglycemic ranges understudied.